Epidemiology and Burden of Sleep Disturbances in Atopic Dermatitis in US Adults.
Journal
Dermatitis : contact, atopic, occupational, drug
ISSN: 2162-5220
Titre abrégé: Dermatitis
Pays: United States
ID NLM: 101207335
Informations de publication
Date de publication:
Historique:
pubmed:
7
3
2021
medline:
23
11
2022
entrez:
6
3
2021
Statut:
ppublish
Résumé
The relationship between atopic dermatitis (AD) severity, sleep disturbance (SD), and health-related outcomes is not fully elucidated. The aim of the study was to determine the prevalence of SD in adult AD and its relationship with AD severity and health outcomes among the US population. A cross-sectional, US population-based survey study of 2893 adults was performed. Among adults meeting the UK Diagnostic Criteria for AD, 255 (40.7%) reported 1 or more, 67 (11.1%) reported 3 to 4, and 57 (9.5%) reported 5 to 7 nights of SD in the past week; 475 (79.7%) reported at least some trouble sleeping in the past 3 days. Moderate and severe Patient-Oriented Scoring AD, Patient-Oriented Eczema Measure, and Numeric Rating Scale-itch and Numeric Rating Scale-skin pain scores were associated with more severe SD compared with those without AD. More frequent and severe SDs were associated with higher Dermatology Life Quality Index, lower 12-item Short-Form Health Survey, and higher Hospital Anxiety and Depression Scale (HADS) scores. Significant mediation by SD severity was observed between Patient-Oriented Eczema Measure and Numeric Rating Scale-itch with Dermatology Life Quality Index, 12-item Short-Form Health Survey physical and mental component scores, HADS-anxiety and HADS-depression scores, diagnosed anxiety, and heart disease. Atopic dermatitis and AD severity are associated with SDs. Sleep disturbances considerably impact quality of life and other health outcomes in adults with AD.
Sections du résumé
BACKGROUND
BACKGROUND
The relationship between atopic dermatitis (AD) severity, sleep disturbance (SD), and health-related outcomes is not fully elucidated.
OBJECTIVE
OBJECTIVE
The aim of the study was to determine the prevalence of SD in adult AD and its relationship with AD severity and health outcomes among the US population.
METHODS
METHODS
A cross-sectional, US population-based survey study of 2893 adults was performed.
RESULTS
RESULTS
Among adults meeting the UK Diagnostic Criteria for AD, 255 (40.7%) reported 1 or more, 67 (11.1%) reported 3 to 4, and 57 (9.5%) reported 5 to 7 nights of SD in the past week; 475 (79.7%) reported at least some trouble sleeping in the past 3 days. Moderate and severe Patient-Oriented Scoring AD, Patient-Oriented Eczema Measure, and Numeric Rating Scale-itch and Numeric Rating Scale-skin pain scores were associated with more severe SD compared with those without AD. More frequent and severe SDs were associated with higher Dermatology Life Quality Index, lower 12-item Short-Form Health Survey, and higher Hospital Anxiety and Depression Scale (HADS) scores. Significant mediation by SD severity was observed between Patient-Oriented Eczema Measure and Numeric Rating Scale-itch with Dermatology Life Quality Index, 12-item Short-Form Health Survey physical and mental component scores, HADS-anxiety and HADS-depression scores, diagnosed anxiety, and heart disease.
CONCLUSIONS
CONCLUSIONS
Atopic dermatitis and AD severity are associated with SDs. Sleep disturbances considerably impact quality of life and other health outcomes in adults with AD.
Identifiants
pubmed: 33675326
doi: 10.1097/DER.0000000000000731
pii: 01206501-900000000-99494
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
S104-S113Informations de copyright
Copyright © 2021 American Contact Dermatitis Society. All Rights Reserved.
Références
Fishbein AB, Vitaterna O, Haugh IM, et al. Nocturnal eczema: review of sleep and circadian rhythms in children with atopic dermatitis and future research directions. J Allergy Clin Immunol 2015;136(5):1170–1177.
Li JC, Fishbein A, Singam V, et al. Sleep disturbance and sleep-related impairment in adults with atopic dermatitis: a cross-sectional study. Dermatitis 2018;29(5):270–277.
Silverberg JI, Garg NK, Paller AS, et al. Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study. J Invest Dermatol 2015;135(1):56–66.
Yu SH, Attarian H, Zee P, et al. Burden of sleep and fatigue in US adults with atopic dermatitis. Dermatitis 2016;27(2):50–58.
Silverberg JI, Gelfand JM, Margolis DJ, et al. Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study. Ann Allergy Asthma Immunol 2018;121(3):340–347.
Cheng BT, Silverberg JI. Depression and psychological distress in US adults with atopic dermatitis. Ann Allergy Asthma Immunol 2019;123(2):179–185.
Patel KR, Immaneni S, Singam V, et al. Association between atopic dermatitis, depression, and suicidal ideation: a systematic review and meta-analysis. J Am Acad Dermatol 2019;80(2):402–410.
Silverberg JI, Gelfand JM, Margolis DJ, et al. Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults. Br J Dermatol 2019;181(3):554–565.
Yu SH, Silverberg JI. Association between atopic dermatitis and depression in US adults. J Invest Dermatol 2015;135(12):3183–3186.
Brunner PM, Silverberg JI, Guttman-Yassky E, et al. Increasing comorbidities suggest that atopic dermatitis is a systemic disorder. J Invest Dermatol 2017;137(1):18–25.
Silverberg J, Garg N, Silverberg NB. New developments in comorbidities of atopic dermatitis. Cutis 2014;93(5):222–224.
Silverberg JI, Gelfand JM, Margolis DJ, et al. Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adults. Ann Allergy Asthma Immunol 2018;121(5):604–612 e603.
Silverberg JI, Greenland P. Eczema and cardiovascular risk factors in 2 US adult population studies. J Allergy Clin Immunol 2015;135(3):721–728 e726.
Strom MA, Fishbein AB, Paller AS, et al. Association between atopic dermatitis and attention deficit hyperactivity disorder in U.S. children and adults. Br J Dermatol 2016;175(5):920–929.
Silverberg JI. Association between childhood eczema and headaches: an analysis of 19 US population-based studies. J Allergy Clin Immunol 2016;137(2):492–499 e495.
Silverberg JI, Paller AS. Association between eczema and stature in 9 US population-based studies. JAMA Dermatol 2015;151(4):401–409.
McKenzie C, Paller AS, Fishbein A, et al. Association between the longitudinal course of AD, sleep disturbance, and overall health in US children. J Allergy Clin Immunol Pract 2020;8(2):812–814.e811.
Garg N, Silverberg JI. Association between eczema and increased fractures, bone or joint injury in adults: a US population-based study. JAMA Dermatol 2015;151(1):33–41.
Strom MA, Silverberg JI. Eczema is associated with childhood speech disorder: a retrospective analysis from the National Survey of Children's Health and the National Health Interview Survey. J Pediatr 2016;168:185–192.e184.
Chiesa Fuxench ZC, Block JK, Boguniewicz M, et al. Atopic dermatitis in America study: a cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the US adult population. J Invest Dermatol 2019;139(3):583–590.
Rowen TS, Gaither TW, Awad MA, et al. Pubic hair grooming prevalence and motivation among women in the United States. JAMA Dermatol 2016;152(10):1106–1113.
Hays RD, Liu H, Kapteyn A. Use of Internet panels to conduct surveys. Behav Res Methods 2015;47(3):685–690.
Heckman CJ, Darlow S, Manne SL, et al. Correspondence and correlates of couples' skin cancer screening. JAMA Dermatol 2013;149(7):825–830.
Williams HC, Burney PG, Pembroke AC, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol 1994;131(3):406–416.
Vakharia PP, Chopra R, Sacotte R, et al. Validation of patient-reported global severity of atopic dermatitis in adults. Allergy 2018;73(2):451–458.
Silverberg JI, Chiesa Fuxench ZC, Gelfand JM, et al. Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adults. Ann Allergy Asthma Immunol 2018;121(6):729–734.e724.
Stalder JF, Barbarot S, Wollenberg A, et al. Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe. Allergy 2011;66(8):1114–1121.
Silverberg JI, Margolis DJ, Boguniewicz M, et al. Validation of five patient-reported outcomes for atopic dermatitis severity in adults. Br J Dermatol 2020;182(1):104–111.
Silverberg JI, Lei D, Yousaf M, et al. Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: a validation study. Ann Allergy Asthma Immunol 2020;125(1):78–83.
Charman CR, Venn AJ, Ravenscroft JC, et al. Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods. Br J Dermatol 2013;169(6):1326–1332.
Silverberg JI, Gelfand JM, Margolis DJ, et al. Pain is a common and burdensome symptom of atopic dermatitis in United States adults. J Allergy Clin Immunol Pract 2019;7:2699–2706.e7.
Rogers A, DeLong LK, Chen SC. Clinical meaning in skin-specific quality of life instruments: a comparison of the Dermatology Life Quality Index and Skindex banding systems. Dermatol Clin 2012;30(2):333–342, x.
Basra MK, Fenech R, Gatt RM, et al. The Dermatology Life Quality Index 1994–2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008;159(5):997–1035.
Jenkinson C, Layte R. Development and testing of the UK SF-12 (Short Form Health Survey). J Health Serv Res Policy 1997;2(1):14–18.
Ware J Jr., Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34(3):220–233.
Silverberg JI, Gelfand JM, Margolis DJ, et al. Measurement properties of the Hospital Anxiety and Depression Scale used in atopic dermatitis in adults. J Invest Dermatol 2019;139(6):1388–1391.
Wittkowski A, Richards HL, Griffiths CE, et al. The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis. J Psychosom Res 2004;57(2):195–200.
Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67(6):361–370.
Karacan I, Thornby JI, Anch M, et al. Prevalence of sleep disturbance in a primarily urban Florida County. Soc Sci Med 1976;10(5):239–244.
Doi Y, Minowa M, Okawa M, et al. Prevalence of sleep disturbance and hypnotic medication use in relation to sociodemographic factors in the general Japanese adult population. J Epidemiol 2000;10(2):79–86.
Schroeck JL, Ford J, Conway EL, et al. Review of safety and efficacy of sleep medicines in older adults. Clin Ther 2016;38(11):2340–2372.
Camfferman D, Kennedy JD, Gold M, et al. Eczema and sleep and its relationship to daytime functioning in children. Sleep Med Rev 2010;14(6):359–369.
Gupta MA, Gupta AK. Sleep-wake disorders and dermatology. Clin Dermatol 2013;31(1):118–126.
Bender BG, Leung DY. Sleep disorders in patients with asthma, atopic dermatitis, and allergic rhinitis. J Allergy Clin Immunol 2005;116(6):1200–1201.
Hillman DR, Lack LC. Public health implications of sleep loss: the community burden. Med J Aust 2013;199(8):S7–S10.
Romanos M, Gerlach M, Warnke A, et al. Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample. J Epidemiol Community Health 2010;64(3):269–273.
Schmitt J, Chen CM, Apfelbacher C, et al. Infant eczema, infant sleeping problems, and mental health at 10 years of age: the prospective birth cohort study LISAplus. Allergy 2011;66(3):404–411.
Vgontzas AN, Liao D, Bixler EO, et al. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep 2009;32(4):491–497.
Ferrie JE, Kivimaki M, Akbaraly TN, et al. Change in sleep duration and type 2 diabetes: the Whitehall II study. Diabetes Care 2015;38(8):1467–1472.
Spiegel K, Knutson K, Leproult R, et al. Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol (1985) 2005;99(5):2008–2019.
Vgontzas AN, Liao D, Pejovic S, et al. Insomnia with objective short sleep duration is associated with type 2 diabetes: a population-based study. Diabetes Care 2009;32(11):1980–1985.
Kobayashi D, Takahashi O, Deshpande GA, et al. Association between weight gain, obesity, and sleep duration: a large-scale 3-year cohort study. Sleep Breath 2012;16(3):829–833.
Navarro-Solera M, Carrasco-Luna J, Pin-Arboledas G, et al. Short sleep duration is related to emerging cardiovascular risk factors in obese children. J Pediatr Gastroenterol Nutr 2015;61(5):571–576.
Watanabe M, Kikuchi H, Tanaka K, et al. Association of short sleep duration with weight gain and obesity at 1-year follow-up: a large-scale prospective study. Sleep 2010;33(2):161–167.
Badran M, Yassin BA, Fox N, et al. Epidemiology of sleep disturbances and cardiovascular consequences. Can J Cardiol 2015;31(7):873–879.
Sabanayagam C, Shankar A. Sleep duration and cardiovascular disease: results from the National Health Interview Survey. Sleep 2010;33(8):1037–1042.
Silverberg JI, Lei D, Yousaf M, et al. Association of atopic dermatitis severity with cognitive function in adults. J Am Acad Dermatol 2020;83(5):1349–1359.
Garg N, Silverberg JI. Association between childhood allergic disease, psychological comorbidity, and injury requiring medical attention. Ann Allergy Asthma Immunol 2014;112(6):525–532.
Kwa MC, Silverberg JI. Association between inflammatory skin disease and cardiovascular and cerebrovascular co-morbidities in US adults: analysis of nationwide inpatient sample data. Am J Clin Dermatol 2017;18:813–823.
Silverberg JI. Selected comorbidities of atopic dermatitis: atopy, neuropsychiatric, and musculoskeletal disorders. Clin Dermatol 2017;35(4):360–366.
Silverberg JI. Comorbidities and the impact of atopic dermatitis. Ann Allergy Asthma Immunol 2019;123(2):144–151.
Silverberg JI, Simpson EL. Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization. Pediatr Allergy Immunol 2013;24(5):476–486.
Silverberg JI. Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies. Allergy 2015;70(10):1300–1308.
Silverberg JI. Role of childhood obesity in atopic dermatitis. Exper Rev Dermatol 2011;6(6):635–642.
Silverberg JI, Becker L, Kwasny M, et al. Central obesity and high blood pressure in pediatric patients with atopic dermatitis. JAMA Dermatol 2015;151(2):144–152.
Silverberg JI, Kleiman E, Lev-Tov H, et al. Association between obesity and atopic dermatitis in childhood: a case-control study. J Allergy Clin Immunol 2011;127(5):1180–1186.e1181.
Silverberg JI, Silverberg NB, Lee-Wong M. Association between atopic dermatitis and obesity in adulthood. Br J Dermatol 2012;166(3):498–504.
Silverberg JI, Simpson EL. Association between obesity and eczema prevalence, severity and poorer health in US adolescents. Dermatitis 2014;25(4):172–181.
Zhang A, Silverberg JI. Association of atopic dermatitis with being overweight and obese: a systematic review and metaanalysis. J Am Acad Dermatol 2015;72(4):606–616.e604.
Badia X, Mascaro JM, Lozano R. Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to change of the DLQI. The Cavide Research Group. Br J Dermatol 1999;141(4):698–702.
Coutanceau C, Stalder JF. Analysis of correlations between patient-oriented SCORAD (PO-SCORAD) and other assessment scores of atopic dermatitis severity and quality of life. Dermatology 2014;229(3):248–255.
Holm EA, Wulf HC, Stegmann H, et al. Life quality assessment among patients with atopic eczema. Br J Dermatol 2006;154(4):719–725.
Herd RM, Tidman MJ, Ruta DA, et al. Measurement of quality of life in atopic dermatitis: correlation and validation of two different methods. Br J Dermatol 1997;136(4):502–507.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19(3):210–216.
Jobanputra R, Bachmann M. The effect of skin diseases on quality of life in patients from different social and ethnic groups in Cape Town, South Africa. Int J Dermatol 2000;39(11):826–831.
Holm EA, Esmann S, Jemec GB. Does visible atopic dermatitis affect quality of life more in women than in men? Gend Med 2004;1(2):125–130.
Twiss J, Meads DM, Preston EP, et al. Can we rely on the Dermatology Life Quality Index as a measure of the impact of psoriasis or atopic dermatitis? J Invest Dermatol 2012;132(1):76–84.
Chalmers JR, Schmitt J, Apfelbacher C, et al. Report from the Third International Consensus Meeting to Harmonise Core Outcome Measures for Atopic Eczema/Dermatitis Clinical Trials (HOME). Br J Dermatol 2014;171(6):1318–1325.
Chalmers JR, Simpson E, Apfelbacher CJ, et al. Report from the Fourth International Consensus Meeting to Harmonize Core Outcome Measures for Atopic Eczema/Dermatitis Clinical Trials (HOME initiative). Br J Dermatol 2016;175(1):69–79.
Gerbens LA, Chalmers JR, Rogers NK, et al; Harmonising Outcome Measures for Eczema (HOME) initiative. Reporting of symptoms in randomized controlled trials of atopic eczema treatments: a systematic review. Br J Dermatol 2016;175(4):678–686.
Gerbens LA, Prinsen CA, Chalmers JR, et al. Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review. Allergy 2017;72(1):146–163.
Heinl D, Chalmers J, Nankervis H, et al. Eczema trials: quality of life instruments used and their relation to patient-reported outcomes. a systematic review. Acta Derm Venereol 2016;96(5):596–601.
Heinl D, Prinsen CA, Deckert S, et al. Measurement properties of adult quality-of-life measurement instruments for eczema: a systematic review. Allergy 2016;71(3):358–370.
Heinl D, Prinsen CAC, Sach T, et al. Measurement properties of quality-of-life measurement instruments for infants, children and adolescents with eczema: a systematic review. Br J Dermatol 2017;176(4):878–889.
Schmitt J, Williams H; HOME Development Group. Harmonising Outcome Measures for Eczema (HOME). Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany. Br J Dermatol 2010;163(6):1166–1168.
Lei D, Yousaf M, Janmohamed SR, et al. Validation of four single-item patient-reported assessments of sleep in adult atopic dermatitis patients. Ann Allergy Asthma Immunol 2020;124:261–266.
Silverberg JI, Gelfand JM, Margolis DJ, et al. Validation and interpretation of Short Form 12 and comparison with Dermatology Life Quality Index in atopic dermatitis in adults. J Invest Dermatol 2019;139(10):2090–2097.e3.
Patel KR, Singam V, Vakharia PP, et al. Measurement properties of three assessments of burden used in atopic dermatitis in adults. Br J Dermatol 2019;180(5):1083–1089.